½ÃÀ庸°í¼­
»óǰÄÚµå
1598798

¿ä·®°è ½ÃÀå : Á¦Ç°, ¿ëµµ ¹× ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Urometer Market by Product (100 ml, 200 ml, 400 ml), Application (Emergency Trauma, Operative Procedures, Palliative Care), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿ä·®°è ½ÃÀåÀº 2023³â 5¾ï 9,971¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 6¾ï 8,468¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 14.65% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 15¾ï 6,190¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

¿ä·®°è ½ÃÀåÀº ÁÖ·Î ÀÇ·á Áø´Ü¿¡¼­ÀÇ ¿ªÇÒ¿¡ ÀÇÇØ Á¤ÀǵǸç, ¸é¹ÐÇÑ Ã¼¾× ±ÕÇü ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ÇʼöÀûÀÎ ¸Å°³ º¯¼öÀÎ ¿ä·® ÃøÁ¤¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ¿ä·®°èÀÇ Çʿ伺Àº ÁßȯÀÚ½Ç, ¼ö¼ú½Ç, ¼ö¼ú ÈÄ È¸º¹±â¿¡ ºó´¢¿Í °°Àº º´Àû »óŸ¦ °¨ÁöÇϰųª ±Þ¼º ½ÅÀå ¼Õ»óÀ» Æò°¡Çϱâ À§ÇØ µÎµå·¯Áý´Ï´Ù. ¿ä·®°è´Â ÁÖ·Î º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿¡¼­ »ç¿ëµÇ¸ç ¼ºÀÎ, ¼Ò¾Æ, ³ëÀÎ Àα¸¿¡ ¸Â´Â ´Ù¾çÇÑ µðÀÚÀÎÀ¸·Î Á¦°øµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¸¸¼º ½ÅÀå ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ºñ´¢±â ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀüÀ¸·Î, IoT ¹× AI¿Í ÅëÇÕµÈ ½º¸¶Æ® ¿ä·®°è¸¦ °³¹ßÇÏ¿© ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ µðÁöÅÐ °Ç°­ Æ®·»µå¿Í ÀÏÄ¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº Á¤È®µµ¿Í È¿À²¼º Çâ»óÀ» ÅëÇØ ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë°ú ¾ö°ÝÇÑ ±ÔÁ¦ Áؼö µî Á¦Ç° °³¹ß ¹× äÅÃÀ» ¹æÇØÇÏ´Â Á¦¾àÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º´¿øÀÇ ¿¹»ê Á¦¾àÀÌ ±¸¸Å °áÁ¤¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ä«Å×ÅÍ Ä¡·á·Î ÀÎÇÑ °¨¿° À§Çè, ±â°èÀû °íÀåÀ̳ª ºÎÀûÀýÇÑ »ç¿ëÀ¸·Î ÀÎÇÑ ºÎÁ¤È®ÇÑ ÃøÁ¤ °¡´É¼º µîÀÇ ¹®Á¦µµ ÀÖ½À´Ï´Ù. À̸¦ ±Øº¹Çϱâ À§Çؼ­´Â ºñħ½ÀÀû ¹æ¹ýÀÇ Çõ½Å°ú ÀÏȸ¿ë, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÇ °³¹ßÀÌ ÇÙ½ÉÀÌ µÉ °ÍÀÔ´Ï´Ù. °¨¿° À§ÇèÀ» ÁÙÀÌ°í Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â ¼ÒÀç¿¡ ´ëÇÑ ¿¬±¸´Â Á¦Ç°ÀÇ ¸Å·ÂÀ» ´õ¿í ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, ȯÀÚ Áß½ÉÀÇ ¼Ö·ç¼Ç°ú °³ÀÎÈ­µÈ ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ±â¾÷Àº Àúºñ¿ë ´ë¾ÈÀ» µµÀÔÇÏ¿© ½ÅÈï±¹ÀÇ ¹ÌÃæÁ· ¼ö¿ä¸¦ Ȱ¿ëÇϰí ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¸¦ À§ÇÑ Áö¼ÓÀûÀÎ ±³À° ¹× ÈÆ·Ã¿¡ ÅõÀÚÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áö¼Ó°¡´É¼ºÀ» À§ÇØ Ä£È¯°æ ¼ÒÀç¿¡ ÃÊÁ¡À» ¸ÂÃß°í Àü·«Àû ÆÄÆ®³Ê½Ê°ú Çù¾÷À» ÅëÇØ ºê·£µå Æ÷Áö¼Å´×À» °­È­ÇÏ°í °æÀï ȯ°æ¿¡¼­ ½ÃÀå Á¡À¯À²À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 5¾ï 9,971¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 6¾ï 8,468¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 15¾ï 6,190¸¸ ´Þ·¯
CAGR(%) 14.65%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿ä·®°è ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿ä¼Ó°è ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ºñ´¢±â°ú ÁúȯÀÇ À¯º´·ü Áõ°¡
    • ³ëÀÎ Àα¸¿Í ÀçÅà ÀÇ·á ½Ã¼³ Áõ°¡
    • ´Ù¾çÇÑ ºñ¿µ¸®´ÜüÀÇ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • Ä«Å×ÅÍ °ü·Ã ¿ä·Î°¨¿°(CAUTI)¿¡ ´ëÇÑ ¿ì·Á Áõ°¡
  • ½ÃÀå ±âȸ
    • ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ ºü¸£°Ô °³¼±µÇ°í ÀÖ½À´Ï´Ù.
    • ¿ä½Ç±Ý¿¡ ´ëÇÑ ÀÎ½Ä °³¼± Ȱµ¿ È®´ë
  • ½ÃÀå °úÁ¦
    • Á¤È®¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : ¿ä·®°è ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿ä·®°è ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿ä·®°è ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿ä·®°è ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¼Òº¯·®°è ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿ä·®°è ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿ä·®°è ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¿ä·®°è ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

¿ä·®°è ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ´Þ¼ºÇÒ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¿ä·®°è ½ÃÀå : Á¦Ç°º°

  • 100ml
  • 200ml
  • 400ml
  • 450ml
  • 500ml

Á¦7Àå ¿ä·®°è ½ÃÀå : ¿ëµµº°

  • ±ä±Þ ¿Ü»ó
  • ¼ö¼ú ÀýÂ÷
  • ¿ÏÈ­ÀÇ·á

Á¦8Àå ¿ä·®°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿ä·®°è ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿ä·®°è ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿ä·®°è ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Advin Health Care
  • Angel Group Co., Ltd.
  • Angiplast Pvt. Ltd.
  • Barisal Surgical
  • Cardinal Health, Inc.
  • Collateral Medical Pvt Ltd, Inc.
  • ConvaTec Inc.
  • Jambu Pershad & Sons
  • Lybrate, Inc.
  • Maisha Care Limited
  • Medline Industries, LP
  • Omex Medical Technology
  • Poly Medicure Ltd.
  • Rudraksh Pharma & Surgico Pvt. Ltd.
  • SPM Medicare Pvt. Ltd.
ksm 24.11.29

The Urometer Market was valued at USD 599.71 million in 2023, expected to reach USD 684.68 million in 2024, and is projected to grow at a CAGR of 14.65%, to USD 1,561.90 million by 2030.

The urometer market, primarily defined by its role in medical diagnostics, focuses on urinary output measurement, an essential parameter for patients requiring close fluid balance monitoring. The necessity of urometers is evident in intensive care units, surgical wards, and during post-operative recovery to detect medical conditions like oliguria or assess acute kidney injury. Urometers are primarily applied in hospitals, clinics, and ambulatory surgical centers, with varied designs catering to adult, pediatric, and geriatric populations. Market growth is driven by the rising prevalence of chronic kidney diseases, increasing geriatric population, and technological advancements in urinary systems. Opportunities lie in developing smart urometers integrated with IoT and AI for real-time monitoring and data analysis, aligning with the digital health trend. This approach can improve patient outcomes through enhanced precision and efficiency. However, limitations include high costs and stringent regulatory compliances that impede rapid product development and adoption. Moreover, hospital budget constraints can affect purchasing decisions. The market also faces challenges like the risk of infection from catheterization and the potential for inaccurate measurements due to mechanical failures or improper use. To overcome these, innovation in non-invasive techniques and the development of disposable, cost-effective urometer solutions could be key. Research into materials that can reduce infection risk and increase comfort can further advance product appeal. The market is dynamic, with increasing demand for patient-centered solutions and personalized healthcare. Therefore, companies could capitalize on unmet needs in emerging economies by introducing low-cost alternatives and invest in continuous education and training for healthcare providers. Strategic partnerships and collaborations, along with focusing on eco-friendly materials for sustainability, can also enhance brand positioning and capture market share in this competitive landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 599.71 million
Estimated Year [2024] USD 684.68 million
Forecast Year [2030] USD 1,561.90 million
CAGR (%) 14.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urometer Market

The Urometer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of urological disorders
    • Increasing geriatric population and home healthcare facilities
    • Rising number of initiatives by various nonprofit organizations
  • Market Restraints
    • Proliferating concerns regarding catheter-associated urinary tract infection (CAUTI)
  • Market Opportunities
    • Rapid improvement in healthcare infrastructure in emerging economies
    • Growth in the initiatives to raise incontinence awareness
  • Market Challenges
    • Concerns regarding accuracy and reliability

Porter's Five Forces: A Strategic Tool for Navigating the Urometer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urometer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urometer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urometer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urometer Market

A detailed market share analysis in the Urometer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urometer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urometer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urometer Market

A strategic analysis of the Urometer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urometer Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Angel Group Co., Ltd., Angiplast Pvt. Ltd., Barisal Surgical, Cardinal Health, Inc., Collateral Medical Pvt Ltd, Inc., ConvaTec Inc., Jambu Pershad & Sons, Lybrate, Inc., Maisha Care Limited, Medline Industries, LP, Omex Medical Technology, Poly Medicure Ltd., Rudraksh Pharma & Surgico Pvt. Ltd., and SPM Medicare Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Urometer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 100 ml, 200 ml, 400 ml, 450 ml, and 500 ml.
  • Based on Application, market is studied across Emergency Trauma, Operative Procedures, and Palliative Care.
  • Based on End-User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of urological disorders
      • 5.1.1.2. Increasing geriatric population and home healthcare facilities
      • 5.1.1.3. Rising number of initiatives by various nonprofit organizations
    • 5.1.2. Restraints
      • 5.1.2.1. Proliferating concerns regarding catheter-associated urinary tract infection (CAUTI)
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid improvement in healthcare infrastructure in emerging economies
      • 5.1.3.2. Growth in the initiatives to raise incontinence awareness
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding accuracy and reliability
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urometer Market, by Product

  • 6.1. Introduction
  • 6.2. 100 ml
  • 6.3. 200 ml
  • 6.4. 400 ml
  • 6.5. 450 ml
  • 6.6. 500 ml

7. Urometer Market, by Application

  • 7.1. Introduction
  • 7.2. Emergency Trauma
  • 7.3. Operative Procedures
  • 7.4. Palliative Care

8. Urometer Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Urometer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Urometer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Urometer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advin Health Care
  • 2. Angel Group Co., Ltd.
  • 3. Angiplast Pvt. Ltd.
  • 4. Barisal Surgical
  • 5. Cardinal Health, Inc.
  • 6. Collateral Medical Pvt Ltd, Inc.
  • 7. ConvaTec Inc.
  • 8. Jambu Pershad & Sons
  • 9. Lybrate, Inc.
  • 10. Maisha Care Limited
  • 11. Medline Industries, LP
  • 12. Omex Medical Technology
  • 13. Poly Medicure Ltd.
  • 14. Rudraksh Pharma & Surgico Pvt. Ltd.
  • 15. SPM Medicare Pvt. Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦